Generic Name


Therapeutic Category


Spironolactone 50 + Frusemide 20

Spironolactone 50 mg + Frusemide 20 mg Tablet





    Each film coated tablet contains:
    Furosemide                  20mg
    Spironolactone             50mg

    Light Blue oblong film-coated tablet with breakline in one side.


    Pharmacotherapeutic Group: Diuretics 

    Pharmacodynamic properties: Furosemide inhibits reabsorption of Na+, Cl- and K+. Spironolactone is a specific antagonist of aldosterone. It increases Na and water excretion but retains K+. Thus it acts both as diuretic and an antihypertensive. It reduces oedema and counteracts secondary aldosteronism caused by vol depletion Na loss. K loss is reduced.

    Pharmacokinetic properties: Bioavailability : 60%; Half life: 1-2 hrs; Excretion : Urine

      INDICATIONS :  Hypertension, Liver Cirrhosis with Ascitis due to liver cirrhosis, Congestive Heart Failure.  Edema associated with heart failure, renal impairment and nephritic syndrome.

     DOSE :  1-4 tabs/day.



    • May be taken with or without food. Probably in the morning. 

    Pregnancy Category: C

    Nursing Mother : No information is available on the use of frusemide during breastfeeding, alternative drugs may be preferred. 

    Storage: Store between 15-30 °C.

    Missed dose: Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


    SPECIAL PRECAUTIONS Concomitant use with ACE inhibitors, monitor fluids and electrolytes including changes in serum K levels. Dilutional hyponatraemia or even a true lowsalt syndrome may develop. General anaesthesia.

    ADVERSE DRUG REACTIONS :  Fluid and electrolyte imbalance, nausea, diarrhoea, blurred vision, headache, dizziness, hypotension, photosensitisation, hepatic dysfunction, hyperglycaemia and glycosuria, rarely bone marrow depression, gynaecomastia, hirsutism, hoarseness, menstrual irregularities, loss of libido, impotence. Potentially Fatal: Severe hyperkalaemia in patients with preexisting renal impairment or taking ACE inhibitors, agranulocytosis, cardiac arrhythmias.

     DRUG INTERACTIONS :   Aminoglycosides and ethacrynic acid (increased ototoxicity), tubocurazine, succinylcholine (effects enhanced). Sucralfate reduces effects of furosemide. Should be given 2 hr apart. NSAIDs reduce natriuretic and antihypertensive effects of furosemide. Corticosteroids may antagonise action. Digoxin levels may be increased. Warfarin effects may be reduced. Potentially Fatal: Potassium supplements or potassium-rich diet, ACE inhibitors, general anaesthetics (reduced vascular responsiveness to catecholamines), lithium toxicity.


    FRUTONE Each box contains:
    10 strip pack of 10 tablets per strip